QP
Quaker Partners
Venture CapitalActiveQuaker Partners is a healthcare investment firm focused on companies based on the U.S. East Coast.
15
Investments
8
Exits
—
AUM
53.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Quaker Partners.
Investment Thesis & Strategy
Quaker Partners invests in various stages of healthcare companies based on the U.S. East Coast. They seek to invest in companies within the healthcare industry.
Investment Activity
Deals per year over the last 11 years
2
20002
20011
20020
20032
20040
20050
20060
20072
20080
20091
2010Portfolio Companies
Selected investments from their portfolio of 15 companies
V
ViroPharma
Biotech · Series A, 0
N
Neurocrine Biosciences
Biotech · Series A, 0
A
Aratana Therapeutics
Healthcare · Series A, 2010
E
Esperion Therapeutics
Biotech · Series A, 2008
A
Aerie Pharmaceuticals
Biotech · Series A, 2008
S
Sucampo Pharmaceuticals
Biotech · Series A, 2004
A
Achillion Pharmaceuticals
Biotech · Series A, 2004
I
Incyte
Biotech · Series A, 2002
C
Chimerix
Biotech · Series A, 2001
A
Amicus Therapeutics
Biotech · Series A, 2001
M
Medivation
Biotech · Series A, 2000
B
BioDelivery Sciences International
Healthcare · Series A, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
VtesseAcquisition2017—
Marinus PharmaceuticalsIPO2014—
Amicus TherapeuticsIPO2013—
Esperion TherapeuticsIPO2013—
Sucampo PharmaceuticalsIPO2013—
Aratana TherapeuticsIPO2013—
Aegerion PharmaceuticalsIPO2012—
BioDelivery Sciences InternationalIPO2009—
Frequently Asked Questions
Quaker Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
EnerTech Capital
Philadelphia, United States · 71 deals
Quaker BioVentures
Philadelphia, United States · 54 deals
MissionOG
Philadelphia, United States · 42 deals
Karlani Capital
Philadelphia, United States · 23 deals
Gabriel Investments
Philadelphia, United States · 11 deals
Penn Medicine Co-Investment Fund
Philadelphia, United States · 9 deals